A detailed history of Waters Parkerson & Co., LLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Waters Parkerson & Co., LLC holds 2,350 shares of DGX stock, worth $322,161. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,350
Previous 2,950 20.34%
Holding current value
$322,161
Previous $404,000 9.65%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$137.09 - $137.09 $82,254 - $82,254
-600 Reduced 20.34%
2,350 $365,000
Q1 2024

May 14, 2024

SELL
$123.78 - $142.11 $12,378 - $14,211
-100 Reduced 3.28%
2,950 $393,000
Q3 2023

Nov 09, 2023

SELL
$121.86 - $144.92 $48,744 - $57,967
-400 Reduced 11.59%
3,050 $372,000
Q2 2023

Aug 14, 2023

SELL
$130.56 - $146.84 $21,542 - $24,228
-165 Reduced 4.56%
3,450 $485,000
Q4 2021

Feb 14, 2022

BUY
$140.36 - $173.01 $23,159 - $28,546
165 Added 4.78%
3,615 $625,000
Q3 2019

Nov 13, 2019

SELL
$97.85 - $107.42 $29,355 - $32,226
-300 Reduced 8.0%
3,450 $369,000
Q1 2019

May 13, 2019

SELL
$80.68 - $89.92 $10,085 - $11,240
-125 Reduced 3.23%
3,750 $337,000
Q4 2018

Feb 12, 2019

SELL
$79.75 - $108.38 $5,981 - $8,128
-75 Reduced 1.9%
3,875 $323,000
Q2 2018

Aug 13, 2018

BUY
$97.35 - $113.14 $19,470 - $22,628
200 Added 5.33%
3,950 $434,000
Q1 2018

May 09, 2018

SELL
$96.42 - $107.88 $91,599 - $102,486
-950 Reduced 20.21%
3,750 $376,000
Q4 2017

Feb 09, 2018

BUY
$90.86 - $100.24 $31,801 - $35,084
350 Added 8.05%
4,700 $463,000
Q3 2017

Nov 13, 2017

SELL
$91.96 - $108.35 $34,485 - $40,631
-375 Reduced 7.94%
4,350 $407,000
Q2 2017

Aug 11, 2017

BUY
N/A
4,725
4,725 $525,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Waters Parkerson & Co., LLC Portfolio

Follow Waters Parkerson & Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waters Parkerson & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waters Parkerson & Co., LLC with notifications on news.